AI in Blood Pressure Monitoring Market Report Scope & Overview:

The AI in Blood Pressure Monitoring Market was valued at USD 1.24 Billion in 2025 and is expected to reach USD 12.92 Billion by 2035, growing at a CAGR of 26.38% from 2026 to 2035.

The Blood Pressure Monitoring Market AI is still on the rise due to the increased number of cases of hypertension and heart disease, increase in demand for constant and noninvasive monitoring, and increased use of health technology by consumers. The advent of artificial intelligence will allow patients and healthcare workers to monitor the blood pressure and other vital signs in real-time through the use of generative AI models that make it possible to collect the data remotely and easily as compared to the use of the conventional cuff measurements. The industry players are still focusing on the geographical expansion strategy in order to keep their position in the emerging market.

Omron Healthcare launched a new series of home blood pressure monitors in May 2025 featuring integrated artificial intelligence for the detection of atrial fibrillation, with the company's proprietary Intellisense AFib algorithm, based on machine learning, automatically screening for atrial fibrillation with every blood pressure measurement taken.

Market Size and Forecast

• Market Size in 2026E: USD 1.57 Billion
• Market Size by 2035: USD 12.92 Billion
• CAGR: 26.38% from 2026 to 2035
• Fastest Growing Region: Asia Pacific
• Largest Region: North America

To Get more information On AI in Blood Pressure Monitoring Market - Request Free Sample Report

AI in Blood Pressure Monitoring Market Trends

• Cuffless monitoring solutions are gaining rapid adoption as computer vision and photoplethysmography techniques mature.
• Growing geriatric population and rising need for regular monitoring continue driving sustained device adoption.
• Companies are pursuing geographic expansion strategies to extend AI-enabled monitoring into emerging and underserved markets.
• Integration of AI algorithms into consumer wearables continues enhancing diagnostic accuracy for real-time cardiovascular monitoring.
• Telehealth expansion and focus on preventive healthcare continue reinforcing demand for continuous, AI-powered monitoring solutions.

The United States AI in Blood Pressure Monitoring Market Outlook

The United States AI in blood pressure monitoring market was valued at USD 0.55 Billion in 2025 and is expected to reach USD 6.01 Billion by 2035, growing at a CAGR of 27.00% from 2026 to 2035.

The United States led in terms of North American demand for AI in blood pressure monitoring applications, enjoyed the largest share of the national market, and continued to reap the rewards of high levels of digital health device adoption along with increased healthcare expenditure. The rising awareness among consumers regarding home monitoring coupled with a growing prevalence of hypertension and use of wearable devices ensured that the country retained its commercial importance.

Fitbit, which is owned by Google and operates out of San Francisco, California, filed a patent in May 2023 for a small blood pressure monitor that will be embedded within its smartwatch technology by using a pressure-sensing force sensor in conjunction with a photoplethysmography sensor.

AI in Blood Pressure Monitoring Market Segmentation Analysis

• By Device Type, the wearable devices segment held approximately 41.60% share in AI in blood pressure monitoring market in 2025, while the cuffless solutions segment is the fastest growing.
• By Technology, the machine learning segment held approximately 56.10% share in AI in blood pressure monitoring market in 2025, while the computer vision techniques segment is the fastest growing.
• By Application, the hypertension management segment held approximately 37.60% share in AI in blood pressure monitoring market in 2025, while the cardiovascular disease prediction segment is the fastest growing.
• By End Use, the hospitals acute care segment held approximately 45.20% share in AI in blood pressure monitoring market in 2025, while the home care settings segment is the fastest growing.

By Device Type, wearable devices led the market, cuffless solutions grew fastest

The wearable devices segment dominated the device type category in 2025, holding approximately 41.60% of total revenue, favored for their ability to deliver continuous, passive monitoring integrated seamlessly into daily consumer routines. That combination of convenience and continuous data capture keeps wearable devices firmly at the top of the broader device type segmentation across nearly every major consumer and clinical monitoring application.

The cuffless solutions segment is projected to grow at the fastest CAGR during the forecast period, as computer vision and photoplethysmography-based measurement techniques continue maturing to the point of delivering clinically meaningful accuracy without a traditional inflatable cuff. Rising consumer preference for discreet, comfortable monitoring that does not interrupt daily activity continues pushing cuffless technology adoption ahead of the broader device type segmentation.

By Technology, machine learning led the market, computer vision techniques grew fastest

The machine learning segment held the largest technology share in 2025, at approximately 56.10%, anchored by algorithms trained on large volumes of blood pressure readings that continue improving measurement accuracy and enabling automatic detection of cardiovascular abnormalities including atrial fibrillation. That established analytical foundation keeps machine learning firmly at the top of the broader technology segmentation across nearly every AI-enabled blood pressure monitoring device currently on the market.

The computer vision techniques segment is projected to grow at the fastest CAGR during the forecast period, as camera-based measurement approaches continue advancing to extract blood pressure estimates from facial video or fingertip imaging without any physical contact sensor at all. That contactless measurement capability continues pushing computer vision adoption ahead of the broader technology segmentation as manufacturers explore genuinely novel measurement modalities.

By Application, hypertension management led the market, cardiovascular disease prediction grew fastest

The hypertension management segment held the largest application share in 2025, at approximately 37.60%, reflecting the sheer scale of the global hypertensive population that requires lifelong blood pressure monitoring and management. That massive addressable patient population keeps hypertension management firmly at the center of overall AI in blood pressure monitoring demand across nearly every major regional market.

The cardiovascular disease prediction segment is projected to grow at the fastest CAGR during the forecast period, as AI algorithms increasingly analyze blood pressure trend data to identify patients at elevated risk of stroke, heart attack, and other cardiovascular events before symptoms appear. Rising clinical interest in predictive, preventive cardiovascular care continues pushing this application category's growth rate ahead of the broader application segmentation.

By End Use, hospitals acute care led the market, home care settings grew fastest

The hospitals acute care segment held the largest end-use share in 2025, at approximately 45.20%, as hospitals frequently manage patients with cardiovascular conditions who require continuous blood pressure monitoring and data analysis integrated with electronic health record systems. That specialized cardiac care and intensive monitoring capability keeps hospitals firmly at the center of overall AI-driven blood pressure monitoring adoption.

The home care settings segment is projected to grow at the fastest CAGR during the forecast period, driven by growing consumer adoption of smart health devices and rising demand for continuous monitoring outside traditional clinical environments. Expanding telehealth integration continues pushing home care adoption of AI-enabled monitoring ahead of the broader end-use segmentation as preventive, remote healthcare models continue maturing.

Regional Analysis

North America AI in Blood Pressure Monitoring Market Insights

North America held the largest share of the global AI in blood pressure monitoring market in 2025, at over 49.00%, supported by high adoption of digital health tools, rising healthcare spending, and a strong base of leading medical device and consumer electronics companies. Growing consumer awareness of home monitoring continued reinforcing this leadership position throughout the year.

The U.S. represented about 88.10% of the regional revenues owing to its presence of top AI-powered health device suppliers in addition to high healthcare technology spend per capita. The contribution from Canada was also rising but smaller than that of the U.S. owing to its increasing digital health penetration, which ensured North America maintained its lead over all other regions.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe AI in Blood Pressure Monitoring Market Insights

The Europe region occupied a significant share of the global AI in blood pressure monitoring market in 2025, owing to the presence of robust healthcare digitalization efforts and increasing consumer preference for smart health devices. Germany is responsible for about 27.50% of regional revenues because of the high presence of medical device companies and extensive health insurance coverage in the nation.

Countries such as France, UK, and the Nordic region have seen a similar trend due to the adoption of digital health care and preventive care efforts in the large healthcare economies of the region. Continued regulatory support for digital therapeutics is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific AI in Blood Pressure Monitoring Market Insights

Asia Pacific was the fastest-growing region in the global AI in blood pressure monitoring market, driven by rising hypertension prevalence, expanding consumer electronics manufacturing, and growing government-backed digital health initiatives across the region's largest economies. Rapid smartphone and wearable device penetration continued driving regional demand at a pace considerably faster than more mature Western markets.

China was responsible for about 37.60% of the regional revenue, owing to its large production capacity for consumer electronics and increasing use of wearable devices in the country. Japan and South Korea provided major contribution to the regional demand with their strong industries related to consumer electronics and healthcare technologies.

MEA & Latin America AI in Blood Pressure Monitoring Market Insights

The Middle East and Africa region recorded rapid growth in AI in blood pressure monitoring adoption in 2025, driven by expanding digital healthcare access initiatives and growing government investment in remote diagnostic technology across the Gulf states and broader African markets in particular. The UAE accounted for roughly 27.10% of regional revenue, supported by national digital health strategy investment and rising consumer demand for connected health devices.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.90% of regional revenue, where growing digital healthcare adoption continued to support category growth. Mexico and Argentina followed a similar trajectory as regional consumer electronics and digital health adoption expanded further through the remainder of the forecast period.

Growth Drivers: Rising hypertension prevalence and smart device adoption

Rising prevalence of hypertension and cardiovascular diseases, affecting well over a billion people globally, continues to be the central force behind AI in blood pressure monitoring market growth. Increasing demand for continuous and non-invasive monitoring, combined with growing consumer adoption of smart health devices, continues reinforcing structural demand across nearly every major healthcare and consumer electronics market worldwide.

Artificial intelligence enabling patients and healthcare professionals to monitor blood pressure and other vital parameters in real time continues opening genuinely new clinical and consumer use cases beyond what traditional cuff-based measurement could achieve. Growing geriatric population and rising need for regular monitoring, combined with expanding telehealth infrastructure, continue reinforcing sustained demand growth across nearly every major AI in blood pressure monitoring application category.

Restraints: Measurement accuracy validation and regulatory approval complexity

Achieving clinically validated measurement accuracy for cuffless and computer vision-based blood pressure monitoring technology continues posing a genuine technical challenge, as regulatory bodies require extensive clinical validation before approving novel measurement modalities for medical use. That validation burden continues extending time-to-market for genuinely innovative cuffless and contactless monitoring technologies.

The high cost of developing and validating AI-enabled monitoring algorithms, combined with the specialized data science and clinical expertise required, continues restricting market entry to well-capitalized medical device and consumer electronics companies. That cost and expertise barrier continues concentrating the most advanced AI-driven monitoring capability among established industry leaders.

Opportunities: Emerging market expansion and predictive cardiovascular analytics

With the increasing use of digital health products in developing and underdeveloped nations, there is an enormous amount of opportunity for organizations which are ready to tap into this emerging market through geographic expansion. Organizations which can provide affordable and reliable AI-enabled monitoring devices in regions which lack proper healthcare infrastructure can take advantage of the growing demands as more and more countries adopt digital health technologies.

One more area where development is possible is the development of predictive cardiovascular analytics based on AI technology. As the technology becomes more advanced, it is capable of identifying those patients who are at an increased risk of developing cardiovascular disease before any symptoms are observed, which will give a chance to businesses providing such services to capitalize on the growing demand up until 2035.

Recent Developments:

• 2025: 73Health launched an AI-powered remote diagnostics technology in Zambia in January, enhancing healthcare access through remote medical examinations and specialist consultations via its eEva Kit, which allows comprehensive check-ups including blood pressure monitoring and temperature checks.
• 2025: Withings continued expanding its connected health device portfolio with enhanced AI-driven cardiovascular risk assessment features, strengthening its position within the consumer smart health monitoring category.
• 2025: Biobeat Technologies continued advancing its wearable, cuffless blood pressure monitoring platform, targeting hospital remote patient monitoring programs requiring continuous, contactless vital sign tracking capability.

AI in Blood Pressure Monitoring Market key players are:

• A&D Company, Limited
• Aktiia SA
• Beurer GmbH
• Binah.ai
• Biobeat Technologies Ltd.
• Biofourmis, Inc.
• Biospectal SA
• Becton, Dickinson and Company
• Omron Healthcare, Inc.
• Withings SA
• Qardio, Inc.
• iHealth Labs, Inc.
• Masimo Corporation
• Koninklijke Philips N.V.
• Samsung Electronics Co., Ltd.
• Apple Inc.
• Fitbit LLC
• Validic, Inc.
• Health2Sync
• CardieX Limited

AI in Blood Pressure Monitoring Market Report Scope :